Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Early detection, consistent management, and lifestyle changes are crucial for managing HAIR-AN syndrome effectively.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

HAIR-AN syndrome mainly affects obese women and can be improved with early diagnosis and treatment using insulin-sensitizing agents.

The normalized androgen ratio can help manage conditions with excess androgen activity in women.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Birth control pills are effective for treating women with too much male hormone.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.

Hirsutism requires identifying the cause to choose the right treatment, which may include medications like oral contraceptives or dexamethasone.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Accurate diagnosis of PCOS requires comprehensive androgen measurement.

Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

Normal androgen levels need ACTH, and different mechanisms control adrenarche and gonadarche.

Insulin resistance and hyperinsulinism are linked to fertility issues and can worsen symptoms of PCOS.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

Androgens promote beard growth but cause hair loss in androgenetic alopecia, with TGF-β1 as a potential treatment target.

Hirsutism is common among Iraqi women, often without a known cause, but family history is significant.

People with early onset androgenetic alopecia may have a higher chance of metabolic syndrome, especially dyslipidemia.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Dysregulated lipid metabolism may play a role in male pattern baldness.

Hirsutism in women often indicates health issues like polycystic ovarian syndrome and is treated with lifestyle changes, medication, and cosmetic measures.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Clinical features of hyperandrogenism do not predict the success of conventional acne treatment in women.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.